metformin and fenfluramine

metformin has been researched along with fenfluramine in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (36.36)	18.7374
1990's	3 (27.27)	18.2507
2000's	3 (27.27)	29.6817
2010's	1 (9.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Glen, RC; Lowe, R; Mitchell, JB	1
Chlouverakis, C	1
Brun, JM	1
Gibson, A; Lawson, AA; Peattie, P; Roscoe, P; Strong, JA	1
Sapeika, N	1
Gibson, AM; Lawson, AA; Peattie, P	1
Caro, JF; Kolaczynski, JW	1
Andres, E; Blicklé, JF; Brogard, JM; Neyrolles, N	1
Del Prato, S; Erkelens, DW; Leutenegger, M	1

Reviews

2 review(s) available for metformin and fenfluramine

Article	Year
Insulin resistance: site of the primary defect or how the current and the emerging therapies work. Journal of basic and clinical physiology and pharmacology, 1998, Volume: 9, Issue:2-4 Topics: Adipose Tissue; Appetite Depressants; Diabetes Mellitus, Type 2; Female; Fenfluramine; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Ligands; Metformin; Thiazoles; Thiazolidinediones	1998
[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: Administration, Oral; Chromans; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exercise; Fenfluramine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lactones; Lipase; Metformin; Orlistat; Peroxisome Proliferators; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone	1999

Article

Year

Insulin resistance: site of the primary defect or how the current and the emerging therapies work.

Journal of basic and clinical physiology and pharmacology, 1998, Volume: 9, Issue:2-4

Topics: Adipose Tissue; Appetite Depressants; Diabetes Mellitus, Type 2; Female; Fenfluramine; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Ligands; Metformin; Thiazoles; Thiazolidinediones

1998

[Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].

La Revue de medecine interne, 1999, Volume: 20 Suppl 3

Topics: Administration, Oral; Chromans; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exercise; Fenfluramine; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Lactones; Lipase; Metformin; Orlistat; Peroxisome Proliferators; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone

1999

Trials

4 trial(s) available for metformin and fenfluramine

Article	Year
[Antidiabetic efficacy of benfluorex. Clinical data]. Presse medicale (Paris, France : 1983), 1992, Sep-09, Volume: 21, Issue:28 Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Female; Fenfluramine; Humans; Hypolipidemic Agents; Insulin; Lactates; Male; Metformin; Middle Aged; Obesity	1992
Comparison of fenfluramine and metformin in treatment of obesity. Lancet (London, England), 1970, Aug-29, Volume: 2, Issue:7670 Topics: Adult; Appetite Depressants; Body Weight; Clinical Trials as Topic; Female; Fenfluramine; Fluorine; Humans; Metformin; Middle Aged; Obesity; Phenethylamines; Placebos	1970
Weight reduction in obesity. British medical journal, 1969, Apr-26, Volume: 2, Issue:5651 Topics: Appetite Depressants; Female; Fenfluramine; Fluorine; Humans; Metformin; Obesity; Phenethylamines	1969
Six-month efficacy of benfluorex vs. placebo or metformin in diet-failed type 2 diabetic patients. Acta diabetologica, 2003, Volume: 40, Issue:1 Topics: Appetite Depressants; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Fenfluramine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Placebos; Retreatment; Treatment Failure; Treatment Outcome	2003

Other Studies

5 other study(ies) available for metformin and fenfluramine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Dietary and medical treatments of obesity: an evaluative review. Addictive behaviors, 1975, Volume: 1, Issue:1 Topics: Amphetamines; Appetite Depressants; Behavior Therapy; Chorionic Gonadotropin; Diet, Reducing; Evaluation Studies as Topic; Exercise Therapy; Fenfluramine; Group Processes; Hospitalization; Humans; Hypnosis; Metformin; Nutritional Requirements; Obesity; Phenformin; Psychotherapy; Thyroid Hormones	1975
Drugs in obesity. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974, Oct-05, Volume: 48, Issue:48 Topics: Amphetamine; Appetite Depressants; Diet, Reducing; Diuretics; Ephedrine; Fenfluramine; Health Education; Humans; Legislation, Drug; Metformin; Methylcellulose; Motivation; Obesity; Phenformin; Physical Exertion; South Africa; Thyroxine	1974